27626325|t|Chronic Hypobaric Hypoxia Induces Right Ventricular Hypertrophy and Apoptosis in Rats: Therapeutic Potential of Nanocurcumin in Improving Adaptation
27626325|a|Nehra, Sarita, Varun Bhardwaj, Santosh Kar, and Deepika Saraswat. Chronic hypobaric hypoxia induces right ventricular hypertrophy and apoptosis in rats: therapeutic potential of nanocurcumin in improving adaptation. High Alt Med Biol. 17:342-352, 2016.-a sustained work load on the right heart on ascent to high altitudes promotes right ventricular hypertrophy (RVH), which eventually undergoes decompensation and promotes pathological damage. However, the exact set of events leading to damage remains unidentified. Curcumin is a natural antioxidant and antihypertrophic agent, but it has poor biostability. Nanotized curcumin (nanocurcumin) has emerged as a promising agent with improved biostability while retaining the therapeutic properties of curcumin. The present study aimed at analyzing the therapeutic properties of nanocurcumin in ameliorating cardiac damage due to chronic hypobaric hypoxia (HH)-induced RVH in comparison to curcumin. Sprague-Dawley rats exposed to HH (25,000 feet, effective oxygen fraction in air [FIO2] ∼0.08, temperature 28°C ± 1°C, relative humidity 55% ± 2% for 3, 7, 14, and 21 days) developed RVH with increased interstitial collagen content, Fulton's index, and cardiomyocyte cross-sectional area while upregulating atrial natriuretic peptide. Tissue damage due to apoptotic cell death was evident by cytochrome-c / caspase-3 activation and TUNEL assay. Concomitant modulation of cyclic guanosine monophosphate (cGMP)/ cGK-1, calmodulin-dependent protein kinase II (CaMkinase II), and intracellular calcium levels with increased free radical -induced damage and lipid peroxidation further contributed to the right heart pathology. Nanocurcumin supplementation decreased HH -induced RVH and apoptosis while modulating cardiac cGMP / cGK-1 signaling, and maintaining CaMkinase II, intracellular calcium levels and redox status better than curcumin. Nanocurcumin -mediated antiapoptotic effects might have benefited residents and sojourners at high altitude in preventing hypoxic cardiac damage.
27626325	0	7	Chronic	T079	C0205191
27626325	8	25	Hypobaric Hypoxia	T046	C0242184
27626325	34	63	Right Ventricular Hypertrophy	T047	C0162770
27626325	68	77	Apoptosis	T043	C0162638
27626325	81	85	Rats	T015	C0034721
27626325	87	98	Therapeutic	T169	C0302350
27626325	99	108	Potential	T080	C3245505
27626325	112	124	Nanocurcumin	T109,T121,T130	C0010467
27626325	128	137	Improving	T080	C1272745
27626325	138	148	Adaptation	T038	C0392673
27626325	215	222	Chronic	T079	C0205191
27626325	223	240	hypobaric hypoxia	T046	C0242184
27626325	249	278	right ventricular hypertrophy	T047	C0162770
27626325	283	292	apoptosis	T043	C0162638
27626325	296	300	rats	T015	C0034721
27626325	302	313	therapeutic	T169	C0302350
27626325	314	323	potential	T080	C3245505
27626325	327	339	nanocurcumin	T109,T121,T130	C0010467
27626325	343	352	improving	T080	C1272745
27626325	353	363	adaptation	T038	C0392673
27626325	414	423	work load	T081	C0085122
27626325	431	442	right heart	T029	C0225808
27626325	446	470	ascent to high altitudes	T033	C2029400
27626325	480	509	right ventricular hypertrophy	T047	C0162770
27626325	511	514	RVH	T047	C0162770
27626325	544	558	decompensation	T033	C0231187
27626325	572	591	pathological damage	T046	C0016663
27626325	637	643	damage	T169	C1883709
27626325	666	674	Curcumin	T109,T121,T130	C0010467
27626325	680	687	natural	T169	C0205296
27626325	688	699	antioxidant	T121	C0003402
27626325	704	726	antihypertrophic agent	T121	C1254351
27626325	744	756	biostability	T080	C0205360
27626325	758	767	Nanotized	T081	C1553036
27626325	768	776	curcumin	T109,T121,T130	C0010467
27626325	778	790	nanocurcumin	T109,T121,T130	C0010467
27626325	839	851	biostability	T080	C0205360
27626325	872	894	therapeutic properties	T169	C0039798
27626325	898	906	curcumin	T109,T121,T130	C0010467
27626325	949	971	therapeutic properties	T169	C0039798
27626325	975	987	nanocurcumin	T109,T121,T130	C0010467
27626325	991	1003	ameliorating	T169	C0332303
27626325	1004	1011	cardiac	T023	C0018787
27626325	1012	1018	damage	T169	C1883709
27626325	1026	1033	chronic	T079	C0205191
27626325	1034	1051	hypobaric hypoxia	T046	C0242184
27626325	1053	1055	HH	T046	C0242184
27626325	1065	1068	RVH	T047	C0162770
27626325	1086	1094	curcumin	T109,T121,T130	C0010467
27626325	1096	1115	Sprague-Dawley rats	T015	C0034715
27626325	1127	1129	HH	T046	C0242184
27626325	1144	1183	effective oxygen fraction in air [FIO2]	T033	C1821160
27626325	1191	1202	temperature	T081	C0039476
27626325	1215	1232	relative humidity	T081	C0428696
27626325	1279	1282	RVH	T047	C0162770
27626325	1298	1310	interstitial	T029	C0596790
27626325	1311	1319	collagen	T116	C0009325
27626325	1329	1343	Fulton's index	T170	C0918012
27626325	1349	1362	cardiomyocyte	T025	C0225828
27626325	1363	1383	cross-sectional area	T082	C0552389
27626325	1390	1402	upregulating	T044	C0949479
27626325	1403	1429	atrial natriuretic peptide	T116,T123	C0034684
27626325	1431	1444	Tissue damage	T037	C0010957
27626325	1452	1472	apoptotic cell death	T043	C0162638
27626325	1488	1500	cytochrome-c	T116,T126	C0010749
27626325	1503	1512	caspase-3	T116,T126	C0291573
27626325	1513	1523	activation	T044	C0014429
27626325	1528	1539	TUNEL assay	T063	C1515232
27626325	1567	1597	cyclic guanosine monophosphate	T114,T123	C0018338
27626325	1599	1603	cGMP	T114,T123	C0018338
27626325	1606	1611	cGK-1	T116,T126	C3494378
27626325	1613	1651	calmodulin-dependent protein kinase II	T116,T126	C0248868
27626325	1653	1665	CaMkinase II	T116,T126	C0248868
27626325	1672	1685	intracellular	T082	C0178719
27626325	1686	1700	calcium levels	T034	C0428302
27626325	1716	1728	free radical	T104,T123	C0016693
27626325	1738	1744	damage	T037	C0010957
27626325	1749	1767	lipid peroxidation	T044	C0023775
27626325	1795	1806	right heart	T029	C0225808
27626325	1807	1816	pathology	T091	C0030664
27626325	1818	1830	Nanocurcumin	T109,T121,T130	C0010467
27626325	1831	1846	supplementation	T061	C1735596
27626325	1857	1859	HH	T046	C0242184
27626325	1869	1872	RVH	T047	C0162770
27626325	1877	1886	apoptosis	T043	C0162638
27626325	1904	1911	cardiac	T023	C0018787
27626325	1912	1916	cGMP	T114,T123	C0018338
27626325	1919	1924	cGK-1	T116,T126	C3494378
27626325	1925	1934	signaling	T044	C0037080
27626325	1952	1964	CaMkinase II	T116,T126	C0248868
27626325	1966	1979	intracellular	T082	C0178719
27626325	1980	1994	calcium levels	T034	C0428302
27626325	1999	2011	redox status	T044	C0030012
27626325	2024	2032	curcumin	T109,T121,T130	C0010467
27626325	2034	2046	Nanocurcumin	T109,T121,T130	C0010467
27626325	2057	2078	antiapoptotic effects	T033	C0243095
27626325	2128	2141	high altitude	T070	C0238617
27626325	2145	2155	preventing	T169	C1292733
27626325	2156	2163	hypoxic	T046	C0242184
27626325	2164	2171	cardiac	T023	C0018787
27626325	2172	2178	damage	T169	C1883709